Enabling the shift from treatment to prevention in healthcare
Stay up-to-date with LAMPseq on:
Get to know LAMPseq at international trade fairs, exhibitions and conferences.

Prevention in a new dimension - LAMPseq enables solutions for uncomplicated and personal Health Management

LAMPseq is the innovative technology with PCR accuracy and at a fraction of the known cost. Developed during the COVID-19 pandemic and applicable to a wide range of pathogens, it opens up a new dimension in diagnostic testing. Tomorrow’s health is today’s prevention. Testing large numbers of samples at low cost opens the way to affordable testing services for personal preventive health care. Prevention means safety from severe disease progression and cost reduction in the healthcare system.

LAMPseq solutions offer borderless diagnostics.

Die LAMPseq Diagnostics GmbH Bildmarke ist ein orangenes Q, welches aussieht wie eine Lupe

Meet LAMPseq

Would you like to establish personal contact with us? Visit us at international congresses and events!

Ready to give it a try?
Let LAMPseq provide you with quick, efficient and cost-effective support!

The Technology Behind LAMPseq

Ein Wissenschaftler steht im Labor des Biotech Unternehmens LAMPseq Diagnostics in Bonn und bedient ein Sequenziergerät von Illumina

Advances in technology are great, but can be difficult to understand. That’s why we’ve set out to explain the technology of LAMPseq in simple terms. 

Pipetten eines Diagnostikgeräts gefüllt mit Probematerial eines Nukleinsäuretests zur Coronatestung

For an in-depth explanation of the technology behind LAMPseq, we have provided a more comprehensive description of the process. This explanation is supported by a paper published in ‘Nature Biotechnology’ which offers detailed information to those of a more technical acumen.

In 2021, the renowned journal, 'Nature Biotechnology' published study results on the LAMPseq method.

After an independent peer review process scientific study results on the LAMPseq method were published in the renowned journal ‘Nature Biotechnology’. Lead authors of the study are the two founders and shareholders of LAMPseq, Dr. Kerstin Ludwig and Prof. Dr. Jonathan Schmid-Burgk.

LAMPseq Founders & Inventors

Ein Portrait von Dr. Frank Schnnieders, CEO und Biotechnology Entrepreneur, der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Frank
Schnieders

Biotechnology & Pharma Entrepreneur
CEO, Biotechnology Expert & Serial Entrepreneur

Ein Portrait von Professor Jonathan Schmid-Burgk, CSO, Co-Funder und Humangenetiker der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Jonathan
Schmid-Burgk

Professor of Immunology
Co-Founder & CSO

Ein Portrait von Dr. Kerstin Ludwig, CTO, Co-Founderin und Humangenetikerin der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Kerstin
Ludwig

Group Leader Human Genetics
Co-Founder & CTO

Ein Portrait von Dr. Per Hoffmann, CCO und Humangenetiker der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Per
Hoffmann

Genomics Industry Expert
Co-Founder & CCO

Looking to get in touch with LAMPseq?

Die LAMPseq Diagnostics GmbH Bildmarke ist ein orangenes Q, welches aussieht wie eine Lupe

We innovate diagnostics to inform next-level medical decisions.

We are currently in the process of redesigning our website.

In the meantime, you can view some of our work and see what were up to on LinkedIn.

Do you already have a project you want to talk to us about? Get in touch